Activation of mononuclear phagocytes and its relationship to asplenia and phosphatidylserine exposing red blood cells in hemoglobin E/β-thalassemia patients

American Journal of Hematology

Volumn 86, Issue 1, 2011, Pages 89-92

  Banyatsuppasin, Wansa ^a   Butthep, Punnee ^a   Atichartakarn, Vichai ^a   Thakkinstian, Ammarin ^a   Archararit, Napaporn ^a   Pattanapanyasat, Kovit ^b   Chuncharunee, Suporn ^a  

^a MAHIDOL UNIVERSITY   (Thailand)

^b MAHIDOL UNIVERSITY   (Thailand)

Author keywords

[No Author keywords available]

Indexed keywords

HEMOGLOBIN E; LIPOPOLYSACCHARIDE; PHOSPHATIDYLSERINE; TUMOR NECROSIS FACTOR ALPHA;

ASPLENIA; BETA THALASSEMIA; BLOOD TRANSFUSION; CELL ACTIVATION; CELL LEVEL; CELL STIMULATION; ERYTHROCYTE; ERYTHROCYTE TRANSFUSION; FLOW CYTOMETRY; HUMAN; INTERMETHOD COMPARISON; IRON CHELATION; LETTER; MONOCYTOSIS; MONONUCLEAR PHAGOCYTE; PHAGOCYTOSIS; PRIORITY JOURNAL; PROTEIN BLOOD LEVEL; SPLENECTOMY;

ADULT; BETA-THALASSEMIA; FEMALE; HEMATOLOGIC DISEASES; HEMOGLOBIN E; HUMANS; MALE; MIDDLE AGED; PHAGOCYTES; PHOSPHATIDYLSERINES; SPLEEN; YOUNG ADULT;

EID: 78650323782     PISSN: 03618609     EISSN: 10968652     Source Type: Journal    
DOI: 10.1002/ajh.21884     Document Type: Letter

References (24)

1. Olivieri N, Weatherall D. Thalassemias. In: Lilleyman J, Hann I, Blanchette V, editors. Pediatric Hematology, 2nd ed. New York: Churchill Livingstone; 1999. pp 307-326.
2. Fucharoen S, Winichagoon P. Thalassemia and abnormal hemoglobin. Int J Hematol 2002; 76( Suppl 2): S83-S89.
3. Fucharoen S, Winichagoon P. Clinical and hematologic aspects of hemoglobin E/β-thalassemia. Curr Opin Hematol 2000; 7: 106-112.
4. Goodman J, Newman MI, Chapman WC. Disorders of the spleen. In: Greer JP, Foerster J, Lukens JN, et al., editors. Wintrobe's Clinical Hematology, 11th ed. Philadelphia, PA: Lippincott Williams & Wilkins; 2004. pp 1893-1909.
5. Kuypers FA, Yuan J, Lewis RA, et al. Membrane phospholipid asymmetry in human thalassemia. Blood 1998; 91: 3044-3051.
6. Weinberg JB. Mononuclear phagocytes. In: Greer JP, Foerster J, Lukens JN, et al., editors. Wintrobe's Clinical Hematology, 11th ed. Philadelphia, PA: Lippincott Williams & Wilkins; 2004. pp 349-386.
7. Atichartakarn V, Angchaisuksiri P, Aryurachai K, et al. Relationship between hypercoagulable state and erythrocyte phosphatidylserine exposure in splenectomized haemoglobin E/β-thalassaemic patients. Br J Haematol 2002; 118: 893-898.
8. Wiener E, Wanachiwanawin W, Chinprasertsuk S, et al. Increased serum levels of macrophage colony-stimulating factor (M-CSF) in α- and β-thalassaemia syndromes: Correlation with anaemia and monocyte activation. Eur J Haematol 1996; 57: 364-369.
9. Wiener E, Allen D, Porter RJ, et al. Role of FcγRI (CD64) in erythrocyte elimination and its up-regulation in thalassemia. Br J Haematol 1999; 106: 923-930.
10. Kyriakou DS, Alexandrakis MG, Kyriakou ES, et al. Activated peripheral blood and endothelial cells in thalassemia patients. Ann Hematol 2001; 80: 577-583.
11. Belcher JD, Marker PH, Weber JP, Hebbel RP. Activated monocytes in sickle cell disease: Potential role in the activation of vascular endothelium and vaso-occlusion. Blood 2000; 96: 2451-2459.
12. Wun T, Cordoba M, Rangaswami A, et al. Activated monocytes and platelet-monocyte aggregates in patients with sickle cell disease. Clin Lab Haematol 2002; 24: 81-88.
13. Chuncharunee S, Archararit N, Hathirat P, et al. Levels of serum interleukin-6 and tumor necrosis factor-α in postsplenectomized thalassemic patients. J Med Assoc Thai 1997; 80( Suppl 1): S86-S91.
14. 0-thalassaemia/HbE and their clinical significance. J Interferon Cytokine Res 1999; 19: 105-111.
15. Ballart IJ, Estevez ME, Sen L, et al. Progressive dysfunction of monocytes associated with iron overload and age in patients with thalassemia major. Blood 1986; 67: 105-109.
16. Gordeuk VR, Ballou S, Lozanski G, Brittenham GM. Decreased concentrations of tumor necrosis factor-α in supernatants of monocytes from homozygotes for hereditary hemochromatosis. Blood 1992; 79: 1855-1860.
17. Atichartakarn V, Angchaisuksiri P, Aryurachai K, et al. In vivo platelet activation and hyperaggregation in hemoglobin E/β-thalassemia: A consequence of splenectomy. Int J Hematol 2003; 77: 299-303.
18. Atichartakarn V, Likittanasombat K, Chuncharunee S, et al. Pulmonary arterial hypertension in previously splenectomized patients with β-thalassemic disorders. Int J Hematol 2003; 78: 139-145.
19. Wiener E. Impaired phagocyte antibacterial effector functions in β-thalassemia: A likely factor in the increased susceptibility to bacterial infections. Hematology 2003; 8: 35-40.
20. Pittis MG, Estevez ME, Diez RA, et al. Decreased phagolysosomal fusion of peripheral blood monocytes from patients with thalassemia major. Acta Haematol 1994; 92: 66-70.
21. Wanachiwanawin W. Infections in E-β-thalassemia. J Pediatr Hematol Oncol 2000; 22: 581-587.
22. Vento S, Cainelli F, Cesario F. Infections and thalassaemia. Lancet Infect Dis 2006; 6: 226-233.
23. Bisharat N, Omari H, Lavi I, Raz R. Risk of infection and death among post-splenectomy patients. J Infect 2001; 43: 182-186.
24. Jung T, Schauer U, Heusser C, et al. Detection of intracellular cytokines by flow cytometry. J Immunol Methods 1993; 159: 197-207.